Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI)

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorNUNES, Maria Carmo P.
dc.contributor.authorBADANO, Luigi Paolo
dc.contributor.authorMARIN-NETO, J. Antonio
dc.contributor.authorEDVARDSEN, Thor
dc.contributor.authorFERNANDEZ-GOLFIN, Covadonga
dc.contributor.authorBUCCIARELLI-DUCCI, Chiara
dc.contributor.authorPOPESCU, Bogdan A.
dc.contributor.authorUNDERWOOD, Richard
dc.contributor.authorHABIB, Gilbert
dc.contributor.authorZAMORANO, Jose Luis
dc.contributor.authorSARAIVA, Roberto Magalhaes
dc.contributor.authorSABINO, Ester Cerdeira
dc.contributor.authorBOTONI, Fernando A.
dc.contributor.authorBARBOSA, Marcia Melo
dc.contributor.authorBARROS, Marcio Vinicius L.
dc.contributor.authorFALQUETO, Eduardo
dc.contributor.authorSIMOES, Marcus Vinicius
dc.contributor.authorSCHMIDT, Andre
dc.contributor.authorROCHITTE, Carlos Eduardo
dc.contributor.authorROCHA, Manoel Otavio Costa
dc.contributor.authorRIBEIRO, Antonio Luiz Pinho
dc.contributor.authorLANCELLOTTI, Patrizio
dc.date.accessioned2018-07-05T18:03:15Z
dc.date.available2018-07-05T18:03:15Z
dc.date.issued2018
dc.description.abstractAims To develop a document by Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI) to review and summarize the most recent evidences about the non-invasive assessment of patients with Chagas disease, with the intent to set up a framework for standardized cardiovascular imaging to assess cardiovascular morphologic and functional disturbances, as well as to guide the subsequent process of clinical decision-making. Methods and results Chagas disease remains one of the most prevalent infectious diseases in Latin America, and has become a health problem in non-endemic countries. Dilated cardiomyopathy is the most severe manifestation of Chagas disease, which causes substantial disability and early mortality in the socially most productive population leading to a significant economical burden. Prompt and correct diagnosis of Chagas disease requires specialized clinical expertise to recognize the unique features of this disease. The appropriate and efficient use of cardiac imaging is pivotal for diagnosing the cardiac involvement in Chagas disease, to stage the disease, assess patients' prognosis and address management. Echocardiography is the most common imaging modality used to assess, and follow-up patients with Chagas disease. The presence of echocardiographic abnormalities is of utmost importance, since it allows to stage patients according to disease progression. In early stages of cardiac involvement, echocardiography may demonstrate segmental left ventricuar wall motion abnormalities, mainly in the basal segments of inferior, inferolateral walls, and the apex, which cannot be attributed to obstructive coronary artery arteries. The prevalence of segmental wall motion abnormalities varies according to the stage of the disease, reaching about 50% in patients with left ventricular dilatation and dysfunction. Speckle tracking echocardiography allows a more precise and quantitative measurement of the regional myocardial function. Since segmental wall motion abnormalities are frequent in Chagas disease, speckle tracking echocardiography may have an important clinical application in these patients, particularly in the indeterminate forms when abnormalities are more subtle. Speckle tracking echocardiography can also quantify the heterogeneity of systolic contraction, which is associated with the risk of arrhythmic events. Three-dimensional (3D) echocardiography is superior to conventional two-dimensional (2D) echocardiography for assessing more accurately the left ventricular apex and thus to detect apical aneurysms and thrombus in patients in whom ventricular foreshortening is suspected by 2D echocardiography. In addition, 3D echocardiography is more accurate than 2D Simpson s biplane rule for assessing left ventricular volumes and function in patients with significant wall motion abnormalities, including aneurysms with distorted ventricular geometry. Contrast echocardiography has the advantage to enhancement of left ventricular endocardial border, allowing for more accurate detection of ventricular aneurysms and thrombus in Chagas disease. Diastolic dysfunction is an important hallmark of Chagas disease even in its early phases. In general, left ventricular diastolic and systolic dysfunction coexist and isolated diastolic dysfunction is uncommon but may be present in patients with the indeterminate form. Right ventricular dysfunction may be detected early in the disease course, but in general, the clinical manifestations occur late at advanced stages of Chagas cardiomyopathy. Several echocardiographic parameters have been used to assess right ventricular function in Chagas disease, including qualitative evaluation, myocardial performance index, tissue Doppler imaging, tricuspid annular plane systolic excursion, and speckle tracking strain. Cardiac magnetic resonance (CMR) is useful to assess global and regional left ventricular function in patients with Chagas diseases. Myocardial fibrosis is a striking feature of Chagas cardiomyopathy and late gadolinium enhancement (LGE) is used to detect and quantify the extension of myocardial fibrosis. Myocardial fibrosis might have a role in risk stratification of patients with Chagas disease. Limited data are available regarding right ventricular function assessed by CMR in Chagas disease. Radionuclide ventriculography is used for global biventricular function assessment in patients with suspected or definite cardiac involvement in Chagas disease with suboptimal acoustic window and contraindication to CMR. Myocardial perfusion scintigraphy may improve risk stratification to define cardiac involvement in Chagas disease, especially in the patients with devices who cannot be submitted to CMR and in the clinical setting of Chagas patients whose main complaint is atypical chest pain. Detection of reversible ischemic defects predicts further deterioration of left ventricular systolic function and helps to avoid unnecessary cardiac catheterization and coronary angiography. Conclusion Cardiac imaging is crucial to detect the cardiac involvement in patients with Chagas disease, stage the disease and stratify patient risk and address management. Unfortunately, most patients live in regions with limited access to imaging methods and point-of-care, simplified protocols, could improve the access of these remote populations to important information that could impact in the clinical management of the disease. Therefore, there are many fields for further research in cardiac imaging in Chagas disease. How to better provide an earlier diagnosis of cardiac involvement and improve patients risk stratification remains to be addressed using different images modalities.
dc.description.indexMEDLINE
dc.description.sponsorshipBristol NIHR Cardiovascular Biomedical Research Unit at the Bristol Heart Institute, Bristol, UK
dc.identifier.citationEUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, v.19, n.4, p.459-+, 2018
dc.identifier.doi10.1093/ehjci/jex154
dc.identifier.eissn2047-2412
dc.identifier.issn2047-2404
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/26970
dc.language.isoeng
dc.publisherOXFORD UNIV PRESS
dc.relation.ispartofEuropean Heart Journal-Cardiovascular Imaging
dc.rightsrestrictedAccess
dc.rights.holderCopyright OXFORD UNIV PRESS
dc.subjectChagas disease
dc.subjectChagas cardiomyopathy
dc.subjectechocardiography
dc.subjectthree-dimensional echocardiography
dc.subjectspeckle tracking echocardiography
dc.subjectcardiac magnetic resonance
dc.subjectnuclear cardiology
dc.subjectradionuclide ventriculography
dc.subjectmyocardial sympathetic innervation
dc.subject.otherventricular systolic function
dc.subject.otherwall-motion abnormalities
dc.subject.otherheart-disease
dc.subject.othermagnetic-resonance
dc.subject.otherdilated cardiomyopathy
dc.subject.otherprognostic value
dc.subject.otherechocardiographic parameters
dc.subject.otherchronotropic incompetence
dc.subject.othersympathetic denervation
dc.subject.othercerebrovascular events
dc.subject.wosCardiac & Cardiovascular Systems
dc.subject.wosRadiology, Nuclear Medicine & Medical Imaging
dc.titleMultimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI)
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.affiliation.countryInglaterra
hcfmusp.affiliation.countryFrança
hcfmusp.affiliation.countryNoruega
hcfmusp.affiliation.countryItália
hcfmusp.affiliation.countryEspanha
hcfmusp.affiliation.countryRomênia
hcfmusp.affiliation.countryisoit
hcfmusp.affiliation.countryisono
hcfmusp.affiliation.countryisoes
hcfmusp.affiliation.countryisogb
hcfmusp.affiliation.countryisoro
hcfmusp.affiliation.countryisofr
hcfmusp.author.externalNUNES, Maria Carmo P.:Univ Fed Minas Gerais, Sch Med, Dept Internal Med, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Hosp Clin, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil
hcfmusp.author.externalBADANO, Luigi Paolo:Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy
hcfmusp.author.externalMARIN-NETO, J. Antonio:Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Internal Med, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil
hcfmusp.author.externalEDVARDSEN, Thor:Oslo Univ Hosp, Dept Cardiol, Oslo, Norway; Univ Oslo, Oslo, Norway
hcfmusp.author.externalFERNANDEZ-GOLFIN, Covadonga:Hosp Univ Ramon y Cajal, Dept Cardiol, Madrid, Spain
hcfmusp.author.externalBUCCIARELLI-DUCCI, Chiara:Univ Bristol, Bristol Heart Inst, Cardiovasc Biomed Res Unit, Bristol NIHR Biomed Res Unit, Bristol, Avon, England
hcfmusp.author.externalPOPESCU, Bogdan A.:Univ Med & Pharm Carol Davila Euroecolab, Inst Cardiovasc Dis Prof Dr CC Iliescu, Dept Cardiol, Bucharest, Romania
hcfmusp.author.externalUNDERWOOD, Richard:Royal Brompton Hosp, Dept Noninvas Cardiac Imaging, London, England; Harefield Hosp, London, England
hcfmusp.author.externalHABIB, Gilbert:La Timone Hosp, Dept Cardiol, Marseille, France
hcfmusp.author.externalZAMORANO, Jose Luis:Univ Alcala Hosp Ramon y Cajal, Dept Cardiol, Madrid, Spain
hcfmusp.author.externalSARAIVA, Roberto Magalhaes:Fundacao Oswaldo Cruz, Dept Cardiol, Av Brasil 4365, BR-21040360 Rio De Janeiro, Brazil; Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Av Brasil 4365, BR-21040360 Rio De Janeiro, Brazil
hcfmusp.author.externalBOTONI, Fernando A.:Univ Fed Minas Gerais, Sch Med, Dept Internal Med, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Hosp Clin, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil
hcfmusp.author.externalBARBOSA, Marcia Melo:Univ Fed Minas Gerais, Sch Med, Dept Internal Med, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Hosp Clin, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil
hcfmusp.author.externalBARROS, Marcio Vinicius L.:Univ Fed Minas Gerais, Sch Med, Dept Internal Med, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Hosp Clin, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil
hcfmusp.author.externalFALQUETO, Eduardo:Hosp Felicio Rocho, Dept Cardiol, Av Contorno 9530, BR-21040360 Belo Horizonte, MG, Brazil
hcfmusp.author.externalSIMOES, Marcus Vinicius:Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Internal Med, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil
hcfmusp.author.externalSCHMIDT, Andre:Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Internal Med, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil
hcfmusp.author.externalROCHA, Manoel Otavio Costa:Univ Fed Minas Gerais, Sch Med, Dept Internal Med, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Hosp Clin, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil
hcfmusp.author.externalRIBEIRO, Antonio Luiz Pinho:Univ Fed Minas Gerais, Sch Med, Dept Internal Med, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Hosp Clin, Av Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil
hcfmusp.author.externalLANCELLOTTI, Patrizio:Univ Liege Hosp, GIGA Cardiovasc Sci, CHU Sart Tilman, Dept Cardiol,Heart Valve Clin, Liege, Belgium; Anthea Hosp, Grp Villa Maria Care & Res, Dept Cardiol, Bari, Italy
hcfmusp.citation.scopus49
hcfmusp.contributor.author-fmusphcESTER CERDEIRA SABINO
hcfmusp.contributor.author-fmusphcCARLOS EDUARDO ROCHITTE
hcfmusp.description.beginpage459
hcfmusp.description.endpage+
hcfmusp.description.issue4
hcfmusp.description.volume19
hcfmusp.origemWOS
hcfmusp.origem.pubmed29029074
hcfmusp.origem.scopus2-s2.0-85058866659
hcfmusp.origem.wosWOS:000431296600015
hcfmusp.publisher.cityOXFORD
hcfmusp.publisher.countryENGLAND
hcfmusp.relation.referenceAcquatella H, 1999, J AM COLL CARDIOL, V33, P522, DOI 10.1016/S0735-1097(98)00569-5
hcfmusp.relation.referenceAcquatella H, 2007, CIRCULATION, V115, P1124, DOI 10.1161/CIRCULATIONAHA.106.627323
hcfmusp.relation.referenceAmundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040
hcfmusp.relation.referenceAndrade Jadelson Pinheiro de, 2011, Arq Bras Cardiol, V96, P434
hcfmusp.relation.referenceAngheben A, 2015, BLOOD TRANSFUS-ITALY, V13, P540, DOI 10.2450/2015.0040-15
hcfmusp.relation.referenceBadano LP, 2015, EUR HEART J-CARD IMG, V16, P919, DOI 10.1093/ehjci/jev139
hcfmusp.relation.referenceBarbosa MM, 2007, EUR J ECHOCARDIOGR, V8, P204, DOI 10.1016/j.euje.2006.03.011
hcfmusp.relation.referenceBarbosa MM, 2014, ECHOCARDIOGR-J CARD, V31, P623, DOI 10.1111/echo.12426
hcfmusp.relation.referenceBarbosa PRB, 2007, BRAZ J MED BIOL RES, V40, P167, DOI 10.1590/S0100-879X2006005000061
hcfmusp.relation.referenceBarros HVL, 2001, J AM SOC ECHOCARDIOG, V14, P353, DOI 10.1067/mje.2001.111155
hcfmusp.relation.referenceBarros M V L, 2004, Eur J Echocardiogr, V5, P182, DOI 10.1016/S1525-2167(03)00078-7
hcfmusp.relation.referenceBarros ML, 2011, REV SOC BRAS MED TRO, V44, P213, DOI [10.1590/S0037-86822011005000020, 10.1590/s0037-86822011005000020]
hcfmusp.relation.referenceBarros MVL, 2016, J AM SOC ECHOCARDIOG, V29, P368, DOI 10.1016/j.echo.2015.12.008
hcfmusp.relation.referenceBarros MV, 2001, EUR J ECHOCARDIOGR, V2, P94
hcfmusp.relation.referenceBarros MVL, 2002, J AM SOC ECHOCARDIOG, V15, P1197, DOI 10.1067/mje.2002.122966
hcfmusp.relation.referenceBarros MVL, 2001, ECHOCARDIOGR-J CARD, V18, P131, DOI 10.1046/j.1540-8175.2001.00131.x
hcfmusp.relation.referenceBestetti RB, 2011, INT J CARDIOL, V151, P205, DOI 10.1016/j.ijcard.2010.05.033
hcfmusp.relation.referenceBotoni FA, 2013, BIOMED RES INT, DOI 10.1155/2013/849504
hcfmusp.relation.referenceCamargo M E, 1986, Bull Pan Am Health Organ, V20, P233
hcfmusp.relation.referenceCoura JR, 2007, MEM I OSWALDO CRUZ, V102, P113, DOI 10.1590/S0074-02762007000900018
hcfmusp.relation.referenceCoura JR, 2010, NATURE, V465, pS6, DOI 10.1038/nature09221
hcfmusp.relation.referenceRamirez JD, 2009, J CLIN MICROBIOL, V47, P3945, DOI 10.1128/JCM.01601-09
hcfmusp.relation.referenceFreitas HFG, 2005, INT J CARDIOL, V102, P239, DOI 10.1016/j.ijcard.2004.05.025
hcfmusp.relation.referenceGarcia-Alvarez A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000826
hcfmusp.relation.referenceGomes VAM, 2016, J AM SOC ECHOCARDIOG, V29, P679, DOI 10.1016/j.echo.2016.03.007
hcfmusp.relation.referenceHAGAR JM, 1991, NEW ENGL J MED, V325, P763, DOI 10.1056/NEJM199109123251103
hcfmusp.relation.referenceHasselberg NE, 2016, EUR HEART J-CARD IMG, V17, P343, DOI 10.1093/ehjci/jev173
hcfmusp.relation.referenceHiguchi MD, 1999, HEART, V82, P279, DOI 10.1136/hrt.82.3.279
hcfmusp.relation.referenceHiss FC, 2009, JACC-CARDIOVASC IMAG, V2, P164, DOI 10.1016/j.jcmg.2008.09.012
hcfmusp.relation.referenceIssa VS, 2010, CIRC-HEART FAIL, V3, P82, DOI 10.1161/CIRCHEARTFAILURE.109.882035
hcfmusp.relation.referenceCarod-Artal FJ, 2010, LANCET NEUROL, V9, P533, DOI 10.1016/S1474-4422(10)70042-9
hcfmusp.relation.referenceKoberle F., 1974, CIBA F SYMP, V20, P21
hcfmusp.relation.referenceKuschnir E, 1974, ARQ BRAS CARDIOL, V27, P9
hcfmusp.relation.referenceKuschnir E, 1974, ARQ BRAS CARDIOL, V27, P11
hcfmusp.relation.referenceLandesmann MCP, 2011, CLIN NUCL MED, V36, P757, DOI 10.1097/RLU.0b013e31821772a9
hcfmusp.relation.referenceSarabanda AVL, 2011, PACE, V34, P54, DOI 10.1111/j.1540-8159.2010.02896.x
hcfmusp.relation.referenceLima-Costa MF, 2010, STROKE, V41, P2477, DOI 10.1161/STROKEAHA.110.588061
hcfmusp.relation.referenceMarin-Neto J A, 1995, Sao Paulo Med J, V113, P826
hcfmusp.relation.referenceMarin-Neto J A, 1991, Arq Bras Cardiol, V57, P181
hcfmusp.relation.referenceMarin-Neto JA, 2015, CURR CARDIOVASC IMAG, V8, DOI 10.1007/s12410-015-9324-2
hcfmusp.relation.referenceMarin-Neto JA, 1998, INT J CARDIOL, V65, P261, DOI 10.1016/S0167-5273(98)00132-6
hcfmusp.relation.referenceMarin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296
hcfmusp.relation.referenceMarin-Neto JA, 2013, REV SOC BRAS MED TRO, V46, P536, DOI 10.1590/0037-8682-0028-2013
hcfmusp.relation.referenceMARINNETO JA, 1992, AM J CARDIOL, V69, P780, DOI 10.1016/0002-9149(92)90505-S
hcfmusp.relation.referenceMARINNETO JA, 1988, CAN J CARDIOL, V4, P231
hcfmusp.relation.referenceMello Ronaldo Peixoto de, 2012, Arq Bras Cardiol, V98, P421
hcfmusp.relation.referenceMinisterio da Saude. Secretaria de Vigilancia em Saude, 2005, Rev Soc Bras Med Trop, V38 Suppl 3, P7
hcfmusp.relation.referenceMiranda CH, 2011, J NUCL MED, V52, P504, DOI 10.2967/jnumed.110.082032
hcfmusp.relation.referenceMolina RBG, 2006, INT J CARDIOL, V113, P188, DOI 10.1016/j.ijcard.2005.11.010
hcfmusp.relation.referenceMoreira HT, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005571
hcfmusp.relation.referenceMOTT KE, 1965, CIRCULATION, V31, P273
hcfmusp.relation.referenceNascimento CAS, 2013, J AM SOC ECHOCARDIOG, V26, P1424, DOI 10.1016/j.echo.2013.08.018
hcfmusp.relation.referenceNunes MCP, 2015, GLOB HEART, V10, P151, DOI 10.1016/j.gheart.2015.07.006
hcfmusp.relation.referenceNunes MCP, 2011, INT J CARDIOL, V147, P294, DOI 10.1016/j.ijcard.2010.12.044
hcfmusp.relation.referenceNunes MCP, 2009, J AM SOC ECHOCARDIOG, V22, P82, DOI 10.1016/j.echo.2008.11.015
hcfmusp.relation.referenceNunes MCP, 2009, J NEUROL SCI, V278, P96, DOI 10.1016/j.jns.2008.12.015
hcfmusp.relation.referenceNunes MDP, 2008, INT J CARDIOL, V127, P372, DOI 10.1016/j.ijcard.2007.06.012
hcfmusp.relation.referenceNunes MP, 2012, J HEART LUNG TRANSPL, V31, P634, DOI 10.1016/j.healun.2012.01.865
hcfmusp.relation.referenceNunes MDCP, 2004, INT J CARDIOL, V94, P79, DOI 10.1016/j.ijcard.2003.05.003
hcfmusp.relation.referenceNunes MDP, 2005, J AM SOC ECHOCARDIOG, V18, P761, DOI 10.1016/j.echo.2005.01.026
hcfmusp.relation.referenceOliveira BMR, 2009, ECHOCARDIOGR-J CARD, V26, P521, DOI 10.1111/j.1540-8175.2008.00842.x
hcfmusp.relation.referenceOliveira E, 2002, INT J CARDIOL, V82, P49, DOI 10.1016/S0167-5273(01)00599-X
hcfmusp.relation.referenceOtani MM, 2009, TRANSFUSION, V49, P1076, DOI 10.1111/j.1537-2995.2009.02107.x
hcfmusp.relation.referencePazin A, 2006, BRAZ J MED BIOL RES, V39, P483, DOI 10.1590/S0100-879X2006000400008
hcfmusp.relation.referencePazin A, 2007, J AM SOC ECHOCARDIOG, V20, P1338, DOI 10.1016/j.echo.2007.04.029
hcfmusp.relation.referencePeix A, 2013, ARQ BRAS CARDIOL, V100, P114, DOI 10.5935/abc.20130023
hcfmusp.relation.referencePereira CD, 2014, ARQ BRAS CARDIOL, V102, P602, DOI 10.5935/abc.20140068
hcfmusp.relation.referenceNunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046
hcfmusp.relation.referenceNunes MCP, 2012, EXPERT REV CARDIOVAS, V10, P1173, DOI [10.1586/erc.12.111, 10.1586/ERC.12.111]
hcfmusp.relation.referenceNunes MDP, 2010, EUR J ECHOCARDIOGR, V11, P590, DOI 10.1093/ejechocard/jeq022
hcfmusp.relation.referenceNunes MDP, 2010, REV ESP CARDIOL, V63, P788, DOI 10.1016/S0300-8932(10)70181-0
hcfmusp.relation.referenceDuarte JDP, 2011, ARQ BRAS CARDIOL, V96, P300
hcfmusp.relation.referenceRibeiro ALP, 2011, J CARDIOVASC ELECTR, V22, P799, DOI 10.1111/j.1540-8167.2010.02000.x
hcfmusp.relation.referenceDias JCP, 2016, REV SOC BRAS MED TRO, V49, P3, DOI 10.1590/0037-8682-0505-2016
hcfmusp.relation.referencePrata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2
hcfmusp.relation.referenceRassi A, 2000, CLIN CARDIOL, V23, P883
hcfmusp.relation.referenceRassi A, 2007, CIRCULATION, V115, P1101, DOI 10.1161/CIRCULATIONAHA.106.627265
hcfmusp.relation.referenceRassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241
hcfmusp.relation.referenceRassi A, 2009, MEM I OSWALDO CRUZ, V104, P152, DOI 10.1590/S0074-02762009000900021
hcfmusp.relation.referenceRassi DD, 2014, ARQ BRAS CARDIOL, V102, P245, DOI 10.5935/abc.20140003
hcfmusp.relation.referenceRegueiro A, 2013, INT J CARDIOL, V165, P107, DOI 10.1016/j.ijcard.2011.07.089
hcfmusp.relation.referenceRequena-Mendez A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003540
hcfmusp.relation.referenceRibeiro A L, 1998, Rev Soc Bras Med Trop, V31, P301, DOI 10.1590/S0037-86821998000300008
hcfmusp.relation.referenceRibeiro AL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002078
hcfmusp.relation.referenceRibeiro AL, 2012, NAT REV CARDIOL, V9, P576, DOI 10.1038/nrcardio.2012.109
hcfmusp.relation.referenceRibeiro ALP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000632
hcfmusp.relation.referenceRibeiro ALP, 2008, J CARDIOVASC ELECTR, V19, P502, DOI 10.1111/j.1540-8167.2007.01088.x
hcfmusp.relation.referenceRocha ALL, 2006, ANN NONINVAS ELECTRO, V11, P3, DOI 10.1111/j.1542-474X.2006.00054.x
hcfmusp.relation.referenceRocha MOC, 2003, FRONT BIOSCI, V8, pE44, DOI 10.2741/926
hcfmusp.relation.referenceRochitte CE, 2007, ARTIF ORGANS, V31, P259, DOI 10.1111/j.1525-1594.2007.00373.x
hcfmusp.relation.referenceRochitte CE, 2005, J AM COLL CARDIOL, V46, P1553, DOI 10.1016/j.jacc.2005.06.067
hcfmusp.relation.referenceSabino EC, 2013, CIRCULATION, V127, P1105, DOI 10.1161/CIRCULATIONAHA.112.123612
hcfmusp.relation.referenceSimoes MV, 2000, AM J CARDIOL, V86, P975, DOI 10.1016/S0002-9149(00)01133-4
hcfmusp.relation.referenceStrasen J, 2014, CLIN RES CARDIOL, V103, P1, DOI 10.1007/s00392-013-0613-y
hcfmusp.relation.referenceTarleton RL, 2001, INT J PARASITOL, V31, P550, DOI 10.1016/S0020-7519(01)00158-8
hcfmusp.relation.referenceTheodoropoulos TAD, 2008, INT J CARDIOL, V128, P22, DOI 10.1016/j.ijcard.2007.11.057
hcfmusp.relation.referenceTorreao JA, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0200-7
hcfmusp.relation.referenceTORRES FW, 1995, AM HEART J, V129, P995, DOI 10.1016/0002-8703(95)90122-1
hcfmusp.relation.referenceUellendahl M, 2016, ARQ BRAS CARDIOL, V107, P460, DOI 10.5935/abc.20160168
hcfmusp.relation.referenceVianna L G, 1979, Arq Bras Cardiol, V33, P41
hcfmusp.relation.referenceViotti R, 2005, REV ESP CARDIOL, V58, P1037, DOI 10.1016/S1885-5857(06)60436-2
hcfmusp.relation.referenceViotti RJ, 2004, HEART, V90, P655, DOI 10.1136/hrt.2003.018960
hcfmusp.relation.referenceWorld Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P33, DOI 10.2147/IBPC.S70402
hcfmusp.scopus.lastupdate2024-06-09
relation.isAuthorOfPublication7d122e95-afc6-426e-9255-72fdf621b547
relation.isAuthorOfPublicatione2e8fbd4-e06d-4a3f-a0e9-76a4650e56f2
relation.isAuthorOfPublication.latestForDiscovery7d122e95-afc6-426e-9255-72fdf621b547
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_NUNES_Multimodality_imaging_evaluation_of_Chagas_disease_an_expert_2018.PDF
Tamanho:
1.38 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/46
Artigos e Materiais de Revistas Científicas - ODS/03